澳大利亚妊娠贫血市场 – 行业趋势和 2030 年预测

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Healthcare Australia Anemia In Pregnancy Market
请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

澳大利亚妊娠贫血市场 – 行业趋势和 2030 年预测

  • Healthcare
  • Upcoming Report
  • Feb 2023
  • Country Level
  • 350 页面
  • 桌子數： 220
  • 图号： 60
立即购买 立即购买

Australia Anemia In Pregnancy Market

市场规模（十亿美元）

CAGR :  % Diagram

Diagram Forecast Period
 2023 –2030
Diagram Market Size (Base Year)
 USD 160.71 Billion
Diagram Market Size (Forecast Year)
 USD 315.55 Billion
Diagram CAGR
 %
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Request For Unlock

>澳大利亚妊娠期贫血市场，按原因（叶酸缺乏、缺铁、维生素 B12 缺乏等）、治疗（铁制品、叶酸补充剂等）、给药途径（口服、静脉和肌肉注射）、开处方周数（

澳大利亚妊娠期贫血市场分析及规模

贫血是近年来最普遍的血液疾病之一。随着新治疗方案研发的不断增加以及诊断程序的进步，预计妊娠贫血市场的增长将会增加。女性缺铁是妊娠期贫血最常见的原因。澳大利亚妊娠期贫血的发病率高于之前的估计，在三级公立医院环境中以及随着妊娠的进展，贫血的发病率更高。

Data Bridge Market Research 分析了 2023-2030 年预测期内妊娠贫血市场的增长率。在上述预测期内，妊娠贫血市场的预期复合年增长率趋于 8.8% 左右。2022 年市场价值为 1.6071 亿美元，到 2030 年将增长至 3.1555 亿美元。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。

澳大利亚妊娠期贫血市场范围和细分

报告指标

细节

预测期

2022 至 2030 年

基准年

2021

历史岁月

2020（可定制为 2014 - 2019）

定量单位

收入（百万美元）、销量（单位）、定价（美元）

涵盖的领域

原因（叶酸缺乏症、缺铁、维生素 B12 缺乏症等）、治疗（铁制品、叶酸补充剂等）、给药途径（口服、静脉和肌肉注射）、处方周数（< 13 周、13-27 周和 ≥28 周）、最终用户（医院、专科诊所、家庭医疗保健等）、分销渠道（医院药房、零售药房、网上药房等）

涵盖的市场参与者

Viatris Inc.（美国）、Aspen Pharmacare Australia Pty Ltd（澳大利亚）、PharmaCare Laboratories Australia（澳大利亚）、AFT Pharmaceuticals（新西兰）、Bayer AG（德国）、A Nelson & Co Ltd（英国）、BLACKMORES（澳大利亚）和 Care Pharma（印度）

市场机会
  • 慢性肾脏病患病率不断上升
  • 增加协议与合作

市场定义

贫血是指身体无法产生足够的红细胞来将氧气输送到组织的一种疾病。怀孕期间贫血很常见，因为身体需要足够的血液来支持婴儿的成长。妇女在怀孕期间摄入的正常营养物质不足，因为在怀孕的中期和晚期对铁和叶酸的需求很高。每个孕妇通常都会出现轻度贫血，但由于体内铁或维生素水平低以及其他原因，贫血的严重程度会加剧。  

澳大利亚妊娠期贫血市场动态

驱动程序

  • 贫血发病率上升

贫血是澳大利亚和世界各地的一种常见疾病，影响着全球超过 15 亿人。它在某些人群中尤其普遍：在澳大利亚，大约 12% 的女性、8% 的学龄前儿童和 20% 的 85 岁以上的人患有贫血。尽管贫血患病率很高，但澳大利亚人口的贫血负担高于一般人群。根据国家心肺血液研究所的数据，预计澳大利亚有 300 万人患有贫血。类风湿性关节炎、肾脏疾病、自身免疫性疾病、肝脏疾病、甲状腺疾病、癌症和炎症性肠病等目标疾病的发病率不断上升，是推动市场增长的主要因素。因此，这促进了市场的增长。

机会

  • 慢性肾脏病患病率不断上升

根据国家肾脏基金会的统计数据，慢性肾脏病 (CKD) 的两个主要病因是糖尿病和高血压。预计每 7 人中就有 1 人（约占澳大利亚成年人的 15%）患有 CKD。2017-18 年，约有 1.0% 的澳大利亚人患有肾脏疾病。自 2011-12 年以来，肾脏疾病的发病率一直保持相对稳定。预计美国等经济发达国家的慢性肾脏病发病率将上升，这意味着未来几年老年人口将增加。 

  • 增加协议与合作  

全球市场参与者发起了多项合同和协议，这也增加了妊娠市场的贫血。例如，Viatris Inc. 于 2021 年宣布该公司参加了 2021 年 6 月 10 日举办的高盛第 42 届年度全球医疗保健会议。该公司的首席执行官和总裁将回答全球出席客户对公司的任何疑问。预计这将提高公司的知名度。这在市场上创造了更多机会。

限制/挑战

  • 铁补充剂的副作用

Few serious effects are related to the intake of iron drugs. Common effects include digestive problems such as nausea, stomach aches, loss of appetite, constipation, and vomiting. The high dose of these drugs may also cause tiredness or weakness, shallow or rapid breathing, bluish skin, fatigue, convulsions, pale skin, or fingernails. Thus, this impedes market growth.

This anemia in pregnancy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the anemia in pregnancy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.  

Australia Anemia in Pregnancy Market Scope

The anemia in pregnancy market is segmented on the basis of cause, treatment, route of administration, prescribing weeks, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Cause

  • Folic Acid Deficiency
  • Iron Deficiency
  • Vitamin B12 Deficiency
  • Others

Treatment

  • Iron Products
  • Folic Acid Supplementation
  • Others

Route of Administration

  • Oral
  • Intravenous
  • Intramuscular

Weeks

  • < 13 Weeks
  • 13-27 Weeks
  • ≥28 Weeks

End-Users

  • Hospitals
  • Specialty Clinics
  • Home Healthcare
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Competitive Landscape and Australia Anemia in Pregnancy Market Share Analysis

The anemia in pregnancy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Australia presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to anemia in pregnancy market.

Key players operating in the anemia in pregnancy market include:

  • Viatris Inc. (U.S.)
  • Aspen Pharmacare Australia Pty Ltd (Australia)
  • PharmaCare Laboratories Australia (Australia)
  • AFT Pharmaceuticals (New Zealand)
  • Bayer AG (Germany)
  • A Nelson & Co Ltd (U.K.)
  • BLACKMORES (Australia)
  • Care Pharma (India)

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of THE Australia anemia in pregnancy MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. Australia ANEMIA IN PREGNANCY MARKET: SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. CURRENCY AND PRICING
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. primary interviews with key opinion leaders
    7. MULTIVARIATE MODELLING
    8. cause LIFELINE CURVE
    9. DBMR MARKET POSITION GRID
    10. VENDOR SHARE ANALYSIS
    11. MARKET end user COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insights
  5. australia anemia in pregnancy market: regulations
  6. Market Overview
    1. Drivers
      1. risE IN cases of hemodilution in pregnancy
      2. risE IN strict vegetarian women population
      3. increaSE IN r&d for new treaTment options
      4. RISE IN ADVANCEMENTS IN DIAGNOSTIC PROCEDURE
    2. restraints
      1. SIDE EFFECTS OF IRON SUPPLEMENTS DURING PREGNANCY
      2. decreasE IN population of pregnant women during COVID-19
    3. OPPORTUNITIES
      1. Rising healthcare expenditure
      2. IncreasE IN favorable government support for maternal healthcare
      3. Strategic Initiatives by Key market players
    4. CHALLENGES
      1. STRINGENT RULES and REGULATIONS
      2. risE IN competition between market players
  7. IMPACT OF COVID-19 ON THE AUSTRALIA ANEMIA IN PREGNANCY MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY
    4. STRATEGIC DECISIONS BY MANUFACTURERS/ SERVICE PROVIDERS
    5. CONCLUSION
  8. Australia anemia in pregnancy market, By cause
    1. overview
    2. iron deficiency
    3. folic acid deficiency
    4. vitamin b12 deficiency
    5. others
  9. Australia anemia in pregnancy market, By treatment
    1. overview
    2. iron products
      1. intravenous
        1. FERRIC CARBOXYMALTOSE
        2. IRON POLYMALTOSE
        3. IRON SUCROSE
        4. IRON DEXTRAN
      2. oral
        1. FERROUS SULPHATE
        2. FERROUS FUMARATE
        3. OTHERS
    3. folic acid supplementation
    4. others
  10. Australia anemia in pregnancy market, By route of administration
    1. overview
    2. ORAL
      1. By form
        1. TABLET
          1. CONTROLLED RELEASE TABLET
          2. NON-CONTROLLED RELEASE TABLET
        2. SACHETS
        3. SYRUP
        4. OTHERS
      2. by iron strength
        1. >50 MG
        2. 50 to 100 MG
        3. <100 MG
    3. INTRAVENOUS
      1. by type
        1. INFUSION
        2. BOLUS INJECTION
      2. by iron strength
        1. 50 mg/ml
        2. 20 mg/ml
    4. INTRAmuscular
  11. Australia anemia in pregnancy market, By prescribing weeks
    1. overview
    2. ≥28 Weeks
    3. 13-27 Weeks
    4. <13 Weeks
  12. Australia anemia in pregnancy market, By end user
    1. overview
    2. hospitals
    3. specialty clinics
    4. home healthcare
    5. others
  13. Australia anemia in pregnancy market, By distribution channel
    1. overview
    2. hospital pharmacy
    3. retail pharmacy
    4. online pharmacy
    5. others
  14. AUSTRALIA ANEMIA IN PREGNANCY market: COMPANY landscape
    1. company share analysis: AUSTRALIA
  15. Swot analysis
  16. Company profiles
    1. Pharmacare Laboratories Australia
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    2. Viatris Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    3. A Nelson & Co
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    4. Bayer AG
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    5. Aspen Pharmacare Australia Pty Ltd
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    6. AFT Pharmaceuticals
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. BLACKMORES
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    8. Care Pharmaceuticals
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    9. Floradix
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  17. QUESTIONAIRE
  18. related reports

表格列表

TABLE 1 Australia anemia in pregnancy market, By cause, 2019-2028 (USD million)

TABLE 2 Australia anemia in pregnancy market, By treatment, 2019-2028 (USD million)

TABLE 3 Australia Iron Products in Anemia in Pregnancy Market, By Treatment, 2019-2028 (USD Million)

TABLE 4 Australia Intravenous in Anemia in Pregnancy Market, By Treatment, 2019-2028 (USD Million)

TABLE 5 Australia Oral in Anemia in Pregnancy Market, By Treatment, 2019-2028 (USD Million)

TABLE 6 Australia anemia in pregnancy market, By ROUTE OF ADMINISTRATION, 2019-2028 (USD million)

TABLE 7 Australia Oral in Anemia in Pregnancy Market, By Form, 2019-2028 (USD Million)

TABLE 8 Australia Tablet in Anemia in Pregnancy Market, By Route Of Administration, 2019-2028 (USD Million)

TABLE 9 Australia Oral in Anemia in Pregnancy Market, By Iron Strength, 2019-2028 (USD Million)

TABLE 10 Australia Intravenous in Anemia in Pregnancy Market, By Type, 2019-2028 (USD Million)

TABLE 11 Australia Intravenous in Anemia in Pregnancy Market, By Iron Strength, 2019-2028 (USD Million)

TABLE 12 Australia anemia in pregnancy market, By prescribing weeks, 2019-2028 (USD million)

TABLE 13 Australia anemia in pregnancy market, By end user, 2019-2028 (USD million)

TABLE 14 Australia anemia in pregnancy market, By distribution channel, 2019-2028 (USD million)

图片列表

FIGURE 1 Australia ANEMIA IN PREGNANCY market: segmentation

FIGURE 2 Australia ANEMIA IN PREGNANCY MARKET: data triangulation

FIGURE 3 AUSTRALIA ANEMIA IN PREGNANCY MARKET: DROC ANALYSIS

FIGURE 4 Australia ANEMIA IN PREGNANCY MARKET: Australia VS REGIONAL ANALYSIS

FIGURE 5 Australia anemia in pregnancy MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 Australia anemia in pregnancy MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 Australia anemia in pregnancy MARKET: DBMR MARKET POSITION GRID

FIGURE 8 AUSTRALIA ANEMIA IN PREGNANCY MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 Australia anemia in pregnancy MARKET: MARKET end user cOVERAGE GRID

FIGURE 10 AUSTRALIA ANEMIA IN PREGNANCY MARKET: SEGMENTATION

FIGURE 11 rising cases of hemodilution in pregnancy is expected to drive the Australia anemia in pregnancy MARKET in the forecast period of 2021 to 2028

FIGURE 12 iron deficiency segment is expected to account for the largest share of the Australia anemia in pregnancy MARKET in 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND, CHALLENGES OF australia anemia in pregnancy market

FIGURE 14 TOTAL HEALTHCARE EXPENDITURE PER PERSON IN AUSTRALIA (USD tHOUSAND) (fROM 2011-2018)

FIGURE 15 Australia anemia in pregnancy market: By cause, 2020

FIGURE 16 Australia anemia in pregnancy market: By cause, 2019-2028 (USD million)

FIGURE 17 Australia anemia in pregnancy market: By cause, CAGR (2021-2028)

FIGURE 18 Australia anemia in pregnancy market: By cause, LIFELINE CURVE

FIGURE 19 Australia anemia in pregnancy market: By TREATMENT, 2020

FIGURE 20 Australia anemia in pregnancy market: By TREATMENT, 2019-2028 (USD million)

FIGURE 21 Australia anemia in pregnancy market: By TREATMENT, CAGR (2021-2028)

FIGURE 22 Australia anemia in pregnancy market: By TREATMENT, LIFELINE CURVE

FIGURE 23 Australia anemia in pregnancy market: By route of administration, 2020

FIGURE 24 Australia anemia in pregnancy market: By route of administration, 2019-2028 (USD million)

FIGURE 25 Australia anemia in pregnancy market: By route of administration, CAGR (2021-2028)

FIGURE 26 Australia anemia in pregnancy market: By route of administration, LIFELINE CURVE

FIGURE 27 Australia anemia in pregnancy market: By prescribing weeks, 2020

FIGURE 28 Australia anemia in pregnancy market: By prescribing weeks, 2019-2028 (USD million)

FIGURE 29 Australia anemia in pregnancy market: By prescribing weeks, CAGR (2021-2028)

FIGURE 30 Australia anemia in pregnancy market: By prescribing weeks, LIFELINE CURVE

FIGURE 31 Australia anemia in pregnancy market: By end user, 2020

FIGURE 32 Australia anemia in pregnancy market: By end user, 2019-2028 (USD million)

FIGURE 33 Australia anemia in pregnancy market: By end user, CAGR (2021-2028)

FIGURE 34 Australia anemia in pregnancy market: By end user, LIFELINE CURVE

FIGURE 35 Australia anemia in pregnancy market: By distribution channel, 2020

FIGURE 36 Australia anemia in pregnancy market: By distribution channel, 2019-2028 (USD million)

FIGURE 37 Australia anemia in pregnancy market: By distribution channel, CAGR (2021-2028)

FIGURE 38 Australia anemia in pregnancy market: By distribution channel, LIFELINE CURVE

FIGURE 39 Australia Anemia in Pregnancy Market market: company share 2020 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The anemia in pregnancy market was USD 160.71 million in 2022.
The anemia in pregnancy market is projected to grow at a CAGR of 8.8% during the forecast period of 2022-2030.
The Australia Anemia in Pregnancy Market report is segmented by cause, treatment, route of administration, prescribing weeks, end user and distribution channel.
The top players are Viatris Inc.(U.S.), Aspen Pharmacare Australia Pty Ltd (Australia), PharmaCare Laboratories Australia (Australia), AFT Pharmaceuticals (New Zealand), Bayer AG (Germany), A Nelson & Co Ltd (U.K.), BLACKMORES (Australia) and Care Pharma (India)

浏览相关页面

Banner